Osborn Williams & Donohoe LLC reduced its position in shares of McKesson Corporation (NYSE:MCK) by 8.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,315 shares of the company’s stock after selling 852 shares during the period. Osborn Williams & Donohoe LLC’s holdings in McKesson Corporation were worth $1,533,000 at the end of the most recent quarter.
A number of other hedge funds have also recently modified their holdings of the stock. BlackRock Inc. increased its position in McKesson Corporation by 2,026.2% in the first quarter. BlackRock Inc. now owns 14,198,977 shares of the company’s stock worth $2,105,140,000 after buying an additional 13,531,173 shares during the period. Ballentine Partners LLC bought a new position in McKesson Corporation during the first quarter worth about $191,000. Parnassus Investments CA increased its position in McKesson Corporation by 310.0% in the first quarter. Parnassus Investments CA now owns 4,280,594 shares of the company’s stock worth $620,727,000 after buying an additional 3,236,594 shares during the period. Pzena Investment Management LLC increased its position in McKesson Corporation by 1,015.0% in the first quarter. Pzena Investment Management LLC now owns 2,077,104 shares of the company’s stock worth $307,951,000 after buying an additional 1,890,815 shares during the period. Finally, Ameriprise Financial Inc. increased its position in McKesson Corporation by 288.6% in the first quarter. Ameriprise Financial Inc. now owns 1,752,850 shares of the company’s stock worth $259,883,000 after buying an additional 1,301,803 shares during the period. 86.58% of the stock is owned by institutional investors and hedge funds.
McKesson Corporation (NYSE MCK) traded down 0.57% during mid-day trading on Friday, hitting $146.00. 1,980,288 shares of the stock were exchanged. McKesson Corporation has a 52 week low of $114.53 and a 52 week high of $194.66. The firm has a market capitalization of $30.70 billion, a price-to-earnings ratio of 6.62 and a beta of 1.13. The company’s 50-day moving average price is $160.21 and its 200 day moving average price is $152.14.
McKesson Corporation (NYSE:MCK) last released its quarterly earnings results on Thursday, July 27th. The company reported $2.46 EPS for the quarter, missing analysts’ consensus estimates of $2.81 by $0.35. The firm had revenue of $51.05 billion for the quarter, compared to analysts’ expectations of $51.22 billion. McKesson Corporation had a return on equity of 25.76% and a net margin of 2.42%. McKesson Corporation’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same period in the prior year, the firm posted $3.50 earnings per share. Equities research analysts expect that McKesson Corporation will post $12.08 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 2nd. Shareholders of record on Friday, September 1st will be given a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.93%. This is a boost from McKesson Corporation’s previous quarterly dividend of $0.28. The ex-dividend date of this dividend is Wednesday, August 30th. McKesson Corporation’s payout ratio is 5.00%.
TRADEMARK VIOLATION WARNING: “McKesson Corporation (NYSE:MCK) Position Reduced by Osborn Williams & Donohoe LLC” was first posted by Community Financial News and is the property of of Community Financial News. If you are reading this article on another website, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this article can be accessed at https://www.com-unik.info/2017/08/19/osborn-williams-donohoe-llc-sells-852-shares-of-mckesson-corporation-nysemck-updated-updated.html.
A number of equities analysts have issued reports on the company. UBS AG reiterated a “neutral” rating and set a $166.00 price target (up previously from $156.00) on shares of McKesson Corporation in a research note on Monday, June 26th. Vetr downgraded McKesson Corporation from a “strong-buy” rating to a “buy” rating and set a $187.51 target price on the stock. in a research note on Monday, July 17th. Leerink Swann boosted their target price on McKesson Corporation to $170.00 and gave the stock a “market perform” rating in a research note on Thursday, June 29th. Barclays PLC set a $187.00 target price on McKesson Corporation and gave the stock a “buy” rating in a research note on Sunday, June 4th. Finally, Zacks Investment Research upgraded McKesson Corporation from a “hold” rating to a “buy” rating and set a $184.00 price objective on the stock in a research note on Wednesday, July 12th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and nine have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $171.21.
In other news, SVP Erin M. Lampert sold 404 shares of the company’s stock in a transaction that occurred on Tuesday, May 30th. The shares were sold at an average price of $160.53, for a total value of $64,854.12. Following the completion of the sale, the senior vice president now owns 2,003 shares of the company’s stock, valued at approximately $321,541.59. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Chairman John H. Hammergren sold 38,619 shares of the company’s stock in a transaction that occurred on Thursday, June 1st. The stock was sold at an average price of $163.76, for a total transaction of $6,324,247.44. Following the completion of the sale, the chairman now directly owns 19,309 shares of the company’s stock, valued at approximately $3,162,041.84. The disclosure for this sale can be found here. Over the last three months, insiders sold 60,231 shares of company stock valued at $9,830,297. 1.20% of the stock is owned by corporate insiders.
McKesson Corporation Company Profile
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally.
What are top analysts saying about McKesson Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for McKesson Corporation and related companies.